Literature DB >> 29318366

[Surgical innovations in treatment of metastatic colorectal cancer : Complexity of metastatic surgery as example for personalized medicine].

C Hackl1, S M Brunner1, K M Schmidt1, H J Schlitt2.   

Abstract

BACKGROUND: Extensive, bilobular and multifocal colorectal liver metastases (CLM) or metastases that are critically situated require an experienced surgeon and advanced surgical techniques to enable curative resection.
OBJECTIVE: This article describes the toolbox of hepato-oncologic surgery including functional augmentation of liver segments by portal vein embolization/ligation, combinations of ablation and resection, two-stage resections and in situ split liver resection, also known as associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Furthermore, the curative resection of extrahepatic, oligometastatic disease are briefly discussed.
MATERIAL AND METHODS: Review of current literature as well as discussion of the ALPPS procedure, which was developed at our institute.
RESULTS: In recent years, oncologic resections for CLM have been significantly refined, leading to a constant increase of curative resection rates.
CONCLUSION: In a multimodality treatment setting, surgical resection of CLM remains the gold standard curative approach and even in the event of presumed hopeless cases with extensive metastasis, experienced hepatobiliary surgeons must evaluate the resectability of colorectal metastases.

Entities:  

Keywords:  ALPPS; Liver metastasis; Liver resection; Portal vein ligation; Residual liver

Mesh:

Year:  2018        PMID: 29318366     DOI: 10.1007/s00104-017-0583-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  28 in total

1.  Cure model survival analysis after hepatic resection for colorectal liver metastases.

Authors:  Alessando Cucchetti; Alessandro Ferrero; Matteo Cescon; Matteo Donadon; Nadia Russolillo; Giorgio Ercolani; Giacomo Stacchini; Federico Mazzotti; Guido Torzilli; Antonio Daniele Pinna
Journal:  Ann Surg Oncol       Date:  2014-11-15       Impact factor: 5.344

2.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Thomas A Aloia
Journal:  J Clin Oncol       Date:  2009-03-10       Impact factor: 44.544

3.  Early survival and safety of ALPPS: first report of the International ALPPS Registry.

Authors:  Erik Schadde; Victoria Ardiles; Ricardo Robles-Campos; Massimo Malago; Marcel Machado; Roberto Hernandez-Alejandro; Olivier Soubrane; Andreas A Schnitzbauer; Dimitri Raptis; Christoph Tschuor; Henrik Petrowsky; Eduardo De Santibanes; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

4.  Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.

Authors:  Michael Linecker; Bergthor Björnsson; Gregor A Stavrou; Karl J Oldhafer; Georg Lurje; Ulf Neumann; René Adam; Francois-René Pruvot; Stefan A Topp; Jun Li; Ivan Capobianco; Silvio Nadalin; Marcel Autran Machado; Sergey Voskanyan; Deniz Balci; Roberto Hernandez-Alejandro; Fernando A Alvarez; Eduardo De Santibañes; Ricardo Robles-Campos; Massimo Malagó; Michelle L de Oliveira; Mickael Lesurtel; Pierre-Alain Clavien; Henrik Petrowsky
Journal:  Ann Surg       Date:  2017-11       Impact factor: 12.969

5.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

7.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

8.  Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases.

Authors:  Dennis A Wicherts; Rafael Miller; Robbert J de Haas; Georgia Bitsakou; Eric Vibert; Luc-Antoine Veilhan; Daniel Azoulay; Henri Bismuth; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

9.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

Review 10.  'In-Situ Split' Liver Resection/ALPPS - Historical Development and Current Practice.

Authors:  Hans J Schlitt; Christina Hackl; Sven Arke Lang
Journal:  Visc Med       Date:  2017-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.